medac GmbH
Elizabeth Y. has over 20 years of experience in regulatory affairs and pharmaceutical research. Currently, Elizabeth serves as Manager of Global Regulatory Affairs for New Products at medac GmbH, focusing on regulatory issues for new products globally since May 2020. Prior roles include Manager of Global Regulatory Operations and Project Manager of Drug Regulatory Affairs at medac GmbH, as well as positions at Almirall Hermal GmbH and EA Young Regulatory Affairs, where Elizabeth provided independent regulatory consultation and prepared regulatory applications. With a solid foundation in research as a Senior Research Scientist at AstraZeneca and Parke-Davis, Elizabeth has a robust educational background including a Ph.D. in insulin receptors, a Master's in Neuroscience, and a Bachelor's in Biological Sciences from prestigious institutions. Key skills encompass regulatory strategy, compliance, and extensive knowledge in pharmacological research and drug development processes.
medac GmbH
We are a privately held, medium-sized global pharmaceutical and diagnostics company based in Germany. For more than 50 years we have been committed to high quality products, reliable supply and individual customer services. Today, over 2.000 medac employees worldwide are working together to supply more than 90 countries with our products. Since our foundation we have been specialising in the treatment of oncological, haematological, urological, and autoimmune diseases. Today, we are a leading specialist supplier in oncology and rheumatology. We combine the innovative power of a researching pharmaceutical company with the efficiency of a generics manufacturer and offer both therapeutics and diagnostics. Always putting the needs of patients and healthcare professionals first, we are committed to the refinement of established and the development of new products with additional benefits for patients in specific niche indications with high therapeutic needs.